Ali Razai

Ali frequently speaks at industry conferences about intellectual property and litigation strategy.

Before joining Morgan Lewis, Ali was a partner at a national IP law firm where he served on the firm’s executive committee. Ali also previously seconded as an interim in-house patent counsel at a large multinational corporation.

• Lead trial counsel for a medical device company in a high-stakes patent litigation involving the first FDA-cleared at-home saliva collection device for COVID-19 PCR testing; obtained summary judgment of noninfringement on all patents-in-suit and invalidated the only nonexpired patent-in-suit before the PTAB
• Lead trial counsel for a medical device company in a high-stakes patent litigation and related inter partes review (IPR) proceedings related to solutions for nucleic acid preservation; successfully invalidated five patents, including an unprecedented finding that the patents were invalid for the patent owner’s misconduct before the PTAB during the IPR proceeding
• Lead trial counsel for global apparel company defending against allegations of trademark infringement related to a blockbuster product; obtained summary judgment of noninfringement at the district court and successfully defended the victory on appeal before the US Court of Appeals for the Ninth Circuit
• Lead counsel for a pharmaceutical company in a breach of contract arbitration involving the development of a heart rhythm drug; obtained favorable award after a three-day arbitration
• Lead trial counsel defending a chain of museums against claims of trademark infringement; obtained dismissal of claims at the district court and successfully defended the victory before the US Court of Appeals for the Ninth Circuit
• Lead trial counsel for a leading hot tub manufacturer alleging trade dress infringement against a look-alike product; obtained a favorable settlement, which included the defendant removing the accused product from the US market
• Lead counsel for a pharmaceutical company in a breach of contract arbitration against a global pharmaceutical company involving an Alzheimer’s drug; obtained favorable settlement
• Lead trial counsel in enforcement actions for large consumer products company; successfully represented or advised company in patent, trademark, and trade dress enforcement matters across the United States and in EU and Russia
• Obtained favorable claim rulings and consent judgment on patent validity and infringement for a pharmaceutical company in ANDA litigation
• Obtained jury verdict and injunctive relief for a medical device company